Monoclonal antibodies can be defined as an antibody produced by a single clone of cells; these antibodies can be produced in large quantities in the laboratory. They can be used to carry drugs, toxins, or radioactive substances straight to cancer cells. Monoclonal antibodies are showing promising results in the treatment of chronic diseases such as cancers and rheumatoid arthritis.
Latin America market for Protein A resins is driven by factors such as growing demand for biosimilars and escalating investments into the research and development of new biosimilar products where as increasing awareness about alternate methods to purify monoclonal antibodies is anticipated to hamper the growth of Protein A Resins market. High cost of the Protein A resin is also a major restraining factor for the market growth.
Latin America Protein A Resins Market was worth $59.08 million in 2018 and estimated to be growing at a CAGR of 8.7%, to reach $89.65 million by 2023. The market is showcasing evident potential in the mentioned forecast period due to increasing research on monoclonal antibodies which intern is expected to drive the sales of Protein A resins.
Latin America Protein A resin market is segmented by product type, application, matrix type and end user. Based on product the market is sub-segmented as Natural Protein A Resin and Recombinant Protein A Resin. Recombinant Protein A is estimated to be the fastest growing PRODUCT segment. By application protein A resin market is segmented into Immuno precipitation and Antibody Purification. Immune precipitation is estimated to be the fastest growing. On the basis of Matrix type global Protein A Resin market is analyzed as Glass or Silica, Agarose and Organic Polymer. Agarose accounts for the largest share in matrix type and is estimated to continue its strong share during the forecast period. By end user Protein A market is segmented into Biopharmaceutical Manufacturers, Clinical Research Laboratories and Academic Institutions
By geography Latin America Protein A resin market is analysed under various regions namely Mexico, Argentina and Brazil. Brazil is the largest market for Protein A Resins while Argentina is estimated to be the fastest growing region with a CAGR of XX%
Some of the key companies covered in the report are GE Healthcare, Repligen Corporation, Novasep, Tosoh Bioscience, GenScript, Thermo Fisher Scientific, EMD Millipore and Expedeon Ltd.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product Type
5.1.1 Natural Protein A Resin
5.1.2 Recombinant Protein A Resin
5.2 By Application
5.2.1 Immunoprecipitation
5.2.2 Antibody Purification
5.3 By End Users
5.3.1 Biopharmaceutical Manufacturers
5.3.2 Clinical Research Laboratories
5.3.3 Academic Institutes
5.4 By Matrix Type
5.4.1 Glass or Silica
5.4.2 Agarose
5.4.3 Organic Polymer
6. Geographical Analysis
6.1 Introduction
6.2 Brazil
6.3 Mexico
6.4 Argentina
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Thermo Fisher Scientific
8.3 Repligen
8.4 Tosoh Bioscience
8.5 EMD Millipore
8.6 Novasep
8.7 GenScript
8.8 Expedeon Ltd
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
